Pulsatile secretion of luteinizing hormone in agonadal men before and during testosterone replacement therapy
- 5 Downloads
We have reevaluated the question regarding the pulsatile pattern of LH secretion in agonadal men before and following testosterone replacement therapy. Five normal males were used as a reference group and four agonadal men were studied before and during replacement therapy with testosterone enanthate. All the subjects were sampled every 5 min for 12 h (08:00 to 20:00). Data were analyzed using the statistically based and validated pulse detection program DETECT. The normal subjects showed an LH pulse frequency of 10.2 ± 1.7 peaks/12 h (mean ± SEM) and a mean duration of 48.8 ± 14 min, while in agonadal patients without testosterone replacement the frequency of LH peaks (27.5 ± 2 peaks/12 h) was significantly higher than for normal subjects (p < 0.05), and the mean duration of peaks was lower than in controls (17.2 ± 1.2 min; p < 0.01). Following chronic testosterone enanthate replacement therapy (200 mg im every two weeks) these patients showed an increase in the duration and a significant reduction in the frequency of LH peaks (from 27.5 ± 2 to 18.2 ± 2.1 peaks/12 h; p < 0.01) but pulse frequency remained significantly higher than for normal subjects (p < 0.01). This finding is independent of the choice of p values for false positive detection rate (p = 0.01 or p =0.005), but it does depend on sampling frequency and is influenced by large (four-fold) changes in the thresholds for peak detection. Using a “discrete deconvolution” technique we estimated the instantaneous secretory rate (ISR) for the two groups of patients. The results using ISR corroborated the findings obtained using analysis of observed plasma LH measurements. ISR computation also showed that the duration of the secretory events of the gonadotropes is significantly shorter (p < 0.01) than the one estimated on plasma concen-tration, both in normal subjects and in agonadal patients before and during testosterone administration. In conclusion: LH pulse frequency observed in basal conditions in agonadal men was much higher than previously reported in primary testicular failure; during conventional testosterone replacement therapy LH pulse frequency of agonadal men was significantly reduced but still higher (p < 0.01) than in normal men. This finding is probably related to the subnormal plasma levels of testosterone found in agonadal men during the replacement therapy; the analysis of data using a sampling interval of 10 min gave results similar to previous reports, confirming that the choice of sampling interval can markedly affect the evaluation of frequent LH pulsatile secretion.
KeywordsTestosterone Luteinizing Hormone Luteinizing Hormone Level Testosterone Replacement Therapy Serum Luteinizing Hormone
Unable to display preview. Download preview PDF.
- 11.Marshall J.C., Kelch R.P. Gonadotropin-releasing hormone: role of pulsatile secretion in the regulation of reproduction. N. Engl. J. Med. 375: 1459, 1986.Google Scholar
- 17.Spratt D.I., Carr D.B., Merriam G.R., Scully R.E., Na- rasimha Rao P., Crowley W.F. Jr. The spectrum of abnormal patterns of gonadotropin-releasing hormone secretion in men with idiopathic hypogonadotropic hypogonadism: clinical and laboratory correlations. J. Clin. Endocrinol. Metab. 64: 283, 1987.PubMedCrossRefGoogle Scholar
- 23.Burger C.W., Korsen T., Van Kessel H., Van Dop PA., Caron F.J.M., Schoemaker J. Pulsatile luteinizing hormone patterns in the follicular phase of the menstrual cycle, polycystic ovarian disease (PCOD) and non-PCOD secondary amenorrhea. J. Clin. Endocrinol. Metab. 61: 1126, 1985.PubMedCrossRefGoogle Scholar
- 25.Genazzani A.D, Guardabasso V., Rodbard D. Evaluation of methods for detection of pulsatile hor mone secretion: sensitivity vs. specificity. 71st Endocrine Society Meeting, Seattle, WA, June 1989, P. 452, (Abstract).Google Scholar
- 26.Veldhuis J.D., Evans W.S., Johnson M.L, Wills M.R., Rogol A.D. Physiological properties of the luteinizing hormone pulse signal: impact of intensive and extended venous sampling paradigms on its characterization in healthy men and women. J. Clin. Endocrinol. Metab. 62: 881, 1986.PubMedCrossRefGoogle Scholar
- 27.Forti G., Toscano V., Casilli D., Marella M., Balducci R., Adamo M.V., Santoro S., Grisolia G.A., Pampaloni A., Serio M. Spermatic and peripheral venous plasma concentrations of testosterone, 17-hydroxyprogesterone, an-drostenedione, dehydroepiandrosterone, delta5-an-drostane-3B, 178-diol, dihydrotestosterone, 5a-an-drostane-36,176 and estradiol in boys with idiopathic varicocele in different stages of puberty. J. Clin. Endocrinol. Metab. 61: 322, 1985.PubMedCrossRefGoogle Scholar
- 30.Cole B.R., Shapiro M.B., Rodbard D. Chromatography and elettrophoresis analysis system (CEPHAS): Computerized peak detection and char acterization. In: Simpoolas N. (Ed.), Electrophoresis. Amsterdam, Elsevier/North-Holland, 1978, P. 79.Google Scholar
- 31.Guardabasso V., Oerter K.E., Lademarco M.F, Veldhuis J.D., Rodbard D. Detect’s user guide, 1988.Google Scholar